Triple-negative breast cancer (TNBC) is a clinical subgroup of breast cancer defined by negativity for the estrogen receptor (ER), progesterone receptor, and ERBB2/HER2 gene amplification. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.